Depletion of Extracellular Chemokines by Aspergillus Melanin

Karen T Graf1, Hong Liu2, Scott G Filler2,3

  • 1Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Mbio
|April 17, 2023
PubMed

Insights

Aspergillus fumigatus uses melanin to deplete immune-attracting chemokines, dampening the host response. This melanin-mediated immune evasion is crucial for establishing invasive fungal infections.

Area of Science:

  • Medical Mycology
  • Immunology
  • Molecular Biology

Background:

  • Aspergillus fumigatus is a major airborne fungal pathogen causing life-threatening lung disease.
  • Infection begins with inhaled conidia interacting with lung epithelial cells, which recruit immune cells.
  • Conidial melanin is known to inhibit innate immune cell function, aiding infection establishment.

Purpose of the Study:

  • To investigate additional mechanisms of immune evasion employed by Aspergillus fumigatus.
  • To determine how A. fumigatus alters host innate immune responses beyond direct immune cell inhibition.

Main Methods:

  • In vitro infection of human small airway epithelial cells (HSAEC1-KT) with A. fumigatus.
  • Measurement of extracellular protein and mRNA levels of key chemokines (CXCL10, CCL20).
  • Assessment of chemokine depletion activity by A. fumigatus and purified melanin.

Main Results:

  • A. fumigatus infection decreased extracellular CXCL10 and CCL20 despite increased mRNA levels.
  • The fungus depleted recombinant chemokines independently of host cells, indicating post-translational effects.
  • Melanin was essential and sufficient for this chemokine-depleting activity; mutant strains and purified melanin confirmed this.

Conclusions:

  • Aspergillus fumigatus utilizes melanin to actively deplete host-derived chemokines, suppressing innate immune cell recruitment.
  • This melanin-mediated chemokine depletion represents a novel immune evasion strategy for A. fumigatus.
  • Targeting this mechanism could lead to new therapeutic strategies against invasive aspergillosis.